Yatharth Hospital and Trauma Care Services Limited AI Stock Analysis
Want to see IN:YATHARTH full AI Analyst Report?
Yatharth Hospital and Trauma Care Services Limited (YATHARTH) AI Stock Analysis
Yatharth Hospital and Trauma Care Services Limited
(NSE:YATHARTH)
Strong financial performance, led by revenue growth and a low-debt balance sheet, combined with bullish technical momentum are the main positive drivers; high valuation metrics weigh on the score.
Yatharth Hospital and Trauma Care Services Limited (YATHARTH) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 102.22B
- Dividend Yield
- 0.05%
- Average Volume (3M)
- 33.48K
- Price to Earnings (P/E)
- 53.9
- Beta (1Y)
- 1.27
- Revenue Growth
- 50.40%
- EPS Growth
- 24.94%
- Country
- India
- Employees
- 7,440
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Care Facilities
Yatharth Hospital and Trauma Care Services Limited Business Overview & Revenue Model
Company Description
Established in 2008 and headquartered in Noida, India, Yatharth Hospital & Trauma Care Services Limited operates and manages super-specialty medical facilities across Delhi and Madhya Pradesh. These hospitals offer an extensive range of healthcare se...
Yatharth Hospital and Trauma Care Services Limited Financial Statement Overview
Summary
Strong revenue growth and significantly strengthened balance sheet with low leverage, offset by negative free cash flow and margin pressures.
Income Statement
82Very PositiveBalance Sheet
92Very PositiveCash Flow
65Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.86B | 12.07B | 8.80B | 6.71B | 5.20B | 4.01B |
| Gross Profit | 8.03B | 6.50B | 5.39B | 5.37B | 4.27B | 3.20B |
| EBITDA | 3.63B | 2.92B | 2.36B | 1.96B | 1.37B | 1.13B |
| Net Income | 1.91B | 1.75B | 1.31B | 1.14B | 657.68M | 441.62M |
Balance Sheet | ||||||
| Total Assets | 25.91B | 22.82B | 17.31B | 10.19B | 4.86B | 4.26B |
| Cash, Cash Equivalents and Short-Term Investments | 2.91B | 2.98B | 5.15B | 2.39B | 382.36M | 120.31M |
| Total Debt | 4.68B | 2.64B | 115.86M | 846.47M | 2.67B | 2.64B |
| Total Liabilities | 6.92B | 4.74B | 940.45M | 1.45B | 3.03B | 3.09B |
| Stockholders Equity | 18.76B | 17.81B | 16.05B | 8.74B | 1.83B | 1.17B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -956.83M | -1.61B | -964.43M | 439.70M | 468.01M |
| Operating Cash Flow | 0 | 2.21B | 1.50B | -30.78M | 637.84M | 599.35M |
| Investing Cash Flow | 0 | -6.17B | -4.20B | -2.26B | -203.10M | -521.75M |
| Financing Cash Flow | 0 | 2.56B | 5.19B | 3.04B | -177.48M | -11.24M |
Yatharth Hospital and Trauma Care Services Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YATHARTH, the sentiment is Positive. The current price of 1061.20 is above the 20-day moving average (MA) of 981.31, above the 50-day MA of 1013.33, and above the 200-day MA of 832.53, indicating a bullish trend. The MACD of 14.99 indicates Negative momentum. The RSI at 62.57 is Neutral, neither overbought nor oversold. The STOCH value of 86.92 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:YATHARTH.
Yatharth Hospital and Trauma Care Services Limited Peers Comparison
Overall Rating
IN:YATHARTH77Outperform
IN:ARTEMISMED73Outperform
IN:NH67Neutral
IN:FORTIS64Neutral
IN:MAXHEALTH63Neutral
IN:APOLLOHOSP62Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | INR 102.25B | 53.92 | ― | 0.05% | 50.40% | 24.94% | |
| 73Outperform | INR 50.86B | 43.66 | ― | 0.14% | 14.77% | 8.40% | |
| 67Neutral | INR 380.62B | 44.24 | ― | 0.24% | 71.40% | 1.76% | |
| 64Neutral | INR 577.54B | 55.52 | ― | 0.13% | 17.50% | 2.40% | |
| 63Neutral | INR 919.79B | 66.79 | ― | 0.21% | 15.17% | 1.63% | |
| 62Neutral | INR 1.22T | 54.67 | ― | 0.23% | 19.24% | 34.11% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:YATHARTH | Yatharth Hospital and Trauma Care Services Limited | 1061.20 | 266.52 | 33.54% | |
| IN:APOLLOHOSP | Apollo Hospitals Enterprise Limited | 8515.50 | 1045.73 | 14.00% | |
| IN:ARTEMISMED | Artemis Medicare Services Ltd. | 321.25 | 50.41 | 18.61% | |
| IN:FORTIS | Fortis Healthcare Ltd. | 765.00 | -178.15 | -18.89% | |
| IN:MAXHEALTH | Max Healthcare Institute Ltd | 945.00 | -174.91 | -15.62% | |
| IN:NH | Narayana Hrudayalaya Ltd. | 1862.50 | -160.90 | -7.95% |
Yatharth Hospital and Trauma Care Services Limited Corporate Events
Yatharth Hospital boosts authorised capital and secures major minority investment
Yatharth Hospital & Trauma Care Services Limited’s board has approved an increase in authorised share capital from INR 115 crore to INR 150 crore, subject to shareholder and regulatory approvals, requiring an amendment to its Memorandum of Associatio...
Yatharth Hospital Challenges Large Tax Demands After Final Assessments
Yatharth Hospital and its subsidiaries AKS Medical & Research Centre and Ramraja Multispeciality Hospital have received final income tax assessment orders from the Delhi tax authorities, raising aggregate demands of over Rs. 43 crores in tax and abou...
Yatharth Hospital Files FY 2025-26 Business Responsibility and Sustainability Report
Yatharth Hospital and Trauma Care Services Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26 to the National Stock Exchange of India and BSE Limited in compliance with SEBI disclosure regulatio...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 18, 2026
